Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Epilepsy and depression - A two-way street?

21.02.2005


Researchers have noted a higher incidence of depression among patients with epilepsy than the general population or others with chronic conditions such as diabetes. For a long time, depression was thought to be a complication of epilepsy.



But there is evidence that the connection between epilepsy and depression may be a two-way street, according to research carried out in Sweden and the United States and reviewed at the annual meeting of the American Association for the Advancement of Science (AAAS). "People with a history of depression have a 3 to 7 times higher risk of developing epilepsy," said Dr. Andres Kanner, a specialist on epilepsy at Rush University Medical Center in Chicago. "This kind of information is forcing us to take a second look at the interaction between depression and epilepsy."

Since depression affects about 5.3 percent of the U.S. population and epilepsy about 0.5 to 1 percent, session organizers said, knowledge of any relationships between the two disorders could help physicians find ways to improve care for both groups. The two-way relationship between epilepsy and depression could mean common pathogenic mechanisms are at work, Kanner said.


Studies with rats that are genetically prone to epilepsy show abnormal secretion in the brain of neurotransmitters such as serotonin, norepinephrine, GABA and dopamine. The abnormal secretion patterns of serotonin and norepinephrine in these animals are similar to abnormal patterns for the same neurotransmitters seen in patients with depression, Kanner said. He summarized the evidence for common biological pathways in a paper published in January in the journal Epilepsy Currents. Phillip C. Jobe of the University of Illinois College of Medicine, another speaker at the meeting, also has studied underlying biological factors that may predispose some people to epilepsy and depression.

Common pathways between depression and epilepsy might account for recent data suggesting that patients with a psychiatric history may not respond as well to medication or surgery for treatment of their seizures, Kanner said. He and his colleagues recently studied 90 patients whose seizures failed to respond to antiepileptic medication and underwent brain surgery to remove tissue that was the focus of the seizures. Patients with a lifetime history of depression were less likely to become seizure-free, the researchers found. Kanner said that suggests depression could be a biological marker for a more severe form of epilepsy.

Epilepsy, marked by unprovoked seizures, is caused by recurrent electrical "storms" in the brain. More than 2.5 million Americans of all ages are living with epilepsy, which can develop at any time of life but especially in early childhood and old age, according to the Epilepsy Foundation.

Possible links between depression and epilepsy have been noted since around 400 B.C., when Hippocrates, the Greek physician, reportedly observed, "Melancholics ordinarily become epileptics and epileptics melancholics." Galen, another Greek physician, later wrote a treatise titled "Epilepsy and Melancholy."

Whatever biological links the two disorders may share, clinicians and patients alike need to be more aware of the significant incidence of depression among those with epilepsy, says Dr. Alan Ettinger of the Long Island Jewish Comprehensive Epilepsy Center. That is true, he said, even of patients who exhibit less severe forms of the condition than those treated at specialized clinics and major medical centers.

Ettinger and his colleagues surveyed 775 epilepsy patients in community settings, 395 asthma patients and 362 healthy control subjects. Among those with epilepsy, 36.5 percent reported symptoms of depression, compared to 27.8 percent of asthmatics and 11.8 percent of controls. The study, published in the journal Neurology in September, also found that nearly 39 percent of the patients with epilepsy had never been evaluated for depression. Ettinger said it is important for doctors and patients to understand that those with epilepsy, even mild forms of the condition, face an elevated risk of depression.

"Patients with epilepsy usually respond well to anti-depression medication and with lower doses," Kanner said. "There is a lot of misperception that if you use an antidepressant, it will worsen the seizures. That is not really so." Kanner said a class of drugs called selective serotonin reuptake inhibitors (which include Zoloft, Paxil and Prozac) have proved safe in patients with epilepsy.

Earl Lane | EurekAlert!
Further information:
http://www.aaas.org

More articles from Health and Medicine:

nachricht Tracking movement of immune cells identifies key first steps in inflammatory arthritis
23.01.2017 | Massachusetts General Hospital

nachricht Team discovers how bacteria exploit a chink in the body's armor
20.01.2017 | University of Illinois at Urbana-Champaign

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Quantum optical sensor for the first time tested in space – with a laser system from Berlin

For the first time ever, a cloud of ultra-cold atoms has been successfully created in space on board of a sounding rocket. The MAIUS mission demonstrates that quantum optical sensors can be operated even in harsh environments like space – a prerequi-site for finding answers to the most challenging questions of fundamental physics and an important innovation driver for everyday applications.

According to Albert Einstein's Equivalence Principle, all bodies are accelerated at the same rate by the Earth's gravity, regardless of their properties. This...

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Tracking movement of immune cells identifies key first steps in inflammatory arthritis

23.01.2017 | Health and Medicine

Electrocatalysis can advance green transition

23.01.2017 | Physics and Astronomy

New technology for mass-production of complex molded composite components

23.01.2017 | Process Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>